{
  "source_file": "download (10).pdf",
  "file_path": "data\\notifications\\Central Tax (Rate)\\2021\\download (10).pdf",
  "file_hash": "3b6106871492e33b9a1439031d1870c6cb289e7c361416cbb140ad698b56f996",
  "total_pages": 1,
  "pages": [
    {
      "page_no": 1,
      "text": "[TO BE PUBLISHED IN THE GAZETTE OF INDIA, EXTRAORDINARY, PART II,\nSECTION 3, SUB-SECTION(i)]\nGOVERNMENT OF INDIA\nMINISTRY OF FINANCE\n(Department of Revenue)\nNotification No. 12/2021-Central Tax (Rate)\nNew Delhi, the 30th September, 2021\nG.S.R….(E).- In exercise of the powers conferred by sub-section (1) of section 11 of\nthe Central Goods and Services Tax Act, 2017 (12 of 2017) (hereafter in this notification\nreferred to as “the said Act”), the Central Government, on being satisfied that it is necessary\nin the public interest so to do, on the recommendations of the Council, hereby exempts the\ngoods specified in column (3) of the Table below, falling under the tariff item, sub-heading,\nheading or Chapter as specified in the First Schedule to the Customs Tariff Act, 1975 (51 of\n1975), as the case may be, as specified in the corresponding entry in column (2) of the said\nTable, from so much of the central tax leviable thereon under section 9 of the said Act, as is\nin excess of the amount calculated at the rate as specified in corresponding entry in column\n(4) of the aforesaid Table, namely:-\nTable\nChapter, Heading, Sub- Description of Goods Rate\nSl. No.\nheading or Tariff item\n(1) (2) (3) (4)\n1 30 Tocilizumab Nil\n2 30 Amphotericin B Nil\n3 30 Remdesivir 2.5%\n4 30 Heparin (anti-coagulant) 2.5%\n5 30 Itolizumab 2.5%\n6 30 Posaconazole 2.5%\n7 30 Infliximab 2.5%\n8 30 Bamlanivimab & Etesevimab 2.5%\n9 30 Casirivimab & Imdevimab 2.5%\n10 30 2-Deoxy-D-Glucose 2.5%\n11 30 Favipiravir 2.5%\n2. This notification shall come into force from the 1st day of October, 2021 and remain in\nforce up to and inclusive of the 31st December, 2021.\n[F. No. 190354/206/2021-TRU]\n(Rajeev Ranjan)\nUnder Secretary to the Government of India"
    }
  ]
}